Skip to content

ADXN

Addex Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$2.89
+4.71%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue47.6K30.0K404.1K1.6M1.4M
Cost of Revenue61.3K————
Gross Profit(13.7K)30.0K404.1K1.6M1.4M
Operating Expenses
R&D Expense136.4K190.2K435.2K942.7K7.9M
SG&A Expense2.0M1.9M1.7M2.0M3.3M
General & Admin Expense2.0M1.9M1.7M2.0M3.3M
Selling & Marketing Expense—————
Other Expenses416.2K766.5K1.0M882.2K817.8K
Total Operating Expenses2.6M2.8M3.2M3.9M12.0M
Cost and Expenses2.6M2.8M3.2M3.9M12.0M
Operating Income (EBIT)(2.6M)(2.8M)(2.8M)(2.2M)(10.5M)
Non-Operating
Interest Income——9.2K64.0K29.3K
Interest Expense5.3K2.4K3.5K21.6K48.9K
Net Interest Income(5.3K)(2.4K)5.6K42.4K(19.6K)
Other Non-Op Income/Expense(4.3M)(4.0M)(2.2M)(257.2K)(263.1K)
Non-Operating Income (excl Interest)3.2M4.0M2.2M253.3K235.1K
EBT (Pre-Tax Income)(6.9M)(6.8M)(4.9M)(2.5M)(10.8M)
Income Tax Expense—————
Bottom Line
Net Income(6.9M)(6.7M)7.1M(10.6M)(20.8M)
Earnings from Cont. Ops(6.9M)(6.8M)(4.9M)(2.5M)(10.8M)
Earnings from Discont. Ops(3.4K)114.3K12.0M(8.1M)(10.0M)
Bottom Line Net Income(6.9M)(6.7M)7.1M(10.6M)(20.8M)
Per Share
Basic EPS($5.61)($6.88)$8.40($16.80)($55.20)
Diluted EPS($5.61)($6.88)$8.40($16.80)($55.20)
Revenue Per Share$0.03$0.03$0.49$2.60$3.78
Shares
Basic Shares Outstanding1.5M935000817606619230376540
Diluted Shares Outstanding1.5M935000817606619230376540
Profitability Metrics
EBITDA(5.7M)(6.8M)(4.6M)(2.2M)(10.5M)
D&A39.2K8.5K260.1K306.0K323.1K
EBIT(5.8M)(6.8M)(4.9M)(2.5M)(10.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026